Communicaton below from Jean-Michel Vanderhofstadt, Director General AIPES and Bernard Ponsard, Chairman ERT
Mo---99 Production Activities at NTP Radioisotopes (NTP)
US National Academies of Sciences Engineering and Medicine report on Molybdenum-99 for Medical Imaging
There is some risk of supply reduction in March, when ORIS will shut down during weeks 11 and 12 and in April when there are NRU outages in weeks 16, 17, 18.
Other potential risk periods are May, week 19 and June, week 23.
Prof. Alan Perkins, High Level Group on the Security of Supply of Medical Radioisotopes.
The BNMS is pleased to publish the report on the 'Future Supply of Medical Radioisotopes for the UK 2014'. In context of the impending closure of two of the world's nuclear reactors involved in the production of Molybdenum, the report assesses the potential impact of this on healthcare services in the UK. The report describes predicted shortages in the Molybdenum supply chain in the period 2016 to 2020, the current status of Nuclear Medicine services in the UK, and explores ways of mitigating the impact of these shortages on patient care pathways. The report additionally explores options for non-reactor production of Technetium-99m in the UK and incorporates details of a visit to the Cyclotron Facilities at Edmonton, Alberta and at TRIUMF, Vancouver BC in Canada by members of the report team.